Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non-Hispanic white populations

Diabetic Medicine

Volumn 29, Issue 11, 2012, Pages 1390-1394

  Martinez Larrad M T ^a   Lorenzo, C ^b   Gonzalez Villalpando C ^c   Gabriel, R ^d   Haffner, S M ^e   Serrano Rios M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b University of Texas Health Science Center at San Antonio   (United States)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; AVIGNON INSULIN SENSITIVITY INDEX; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EUROPEAN AMERICAN; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GUTT INSULIN SENSITIVITY INDEX; HISPANIC; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MCAULEY INDEX; METABOLIC SYNDROME X; MEXICO; MODIFIED MATSUDA INDEX; OBESITY; RACE DIFFERENCE; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STUMVOLL INDEX; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84867209737     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03723.x     Document Type: Article

References (27)

1. DeFronzo RA. Lilly Lecture. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1998; 37: 667-687.
2. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-368.
3. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type2 diabetes. Diabetologia. 2003; 46: 3-19.
4. Serrano Ríos M. Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998; 28: S14-S18.
5. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Roles of glucose and insulin resistance in development of type2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-929.
6. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C et al.Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type2 diabetes in Mexican-origin populations?Diabetes Care 2001; 24: 2059-2064.
7. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C et al.Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002; 39: 203-208.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
9. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis Barned NJ, Temple LA et al.Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460-464.
10. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zabala MG, Hernandez-Gonzalez SO et al.The product of tryglicerides and glucose, a simple measure of insulin sensitivity. Comparison with euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347-3351.
11. 0, 120): comparison with other measures. Diabetes Res Clin Pract 2000; 47: 177-184.
12. Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 1999; 23: 512-517.
13. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB, Wagenknecht LE, Stern MP et al.Prediction of type2 diabetes using simple measures of insulin resistance. Diabetes 2003; 52: 463-469.
14. Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001; 24: 796-797.
15. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010; 33: e93.
16. Haffner S, Gonzalez Villalpando C, Hazuda HP, Valdez R, Mykkanen L, Stern M. Prevalence of hypertension in Mexico City and San Antonio, Texas. Circulation 1994; 90: 1542-1549.
17. Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, González-Villalpando C, González-Sánchez JL, Martínez-Calatrava MJ et al.Is waist circumference an essential component of the metabolic syndrome?Diabetes Care 2007; 30: 2141-2142.
18. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al.Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
20. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
21. Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bul 1980; 87: 245-251.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
23. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB Jr, Wagenknecht LE, Stern MP et al.Prediction of type2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003; 52: 463-469.
24. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G et al.Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000; 151: 190-198.
25. Malita FM, Karelis AD, St-Pierre DH, Garrel D, Bastard JP, Tardif A et al.Surrogate indexes vs. euglycaemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women. Diabetes Metab 2006; 32: 251-255.
26. Meigs JB, D'Agostino RB, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594-1600.
27. Lorenzo C, Haffner SM, Stancáková A, Laakso M. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in non-diabetic Finnish offpring of type2 diabetic individuals. J Clin Endocrin Metab 2010; 95: 5082-5090.